welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Label-Free Global Serum Proteomic Profiling Reveals Novel Celecoxib-Modulated Proteins in Familial Adenomatous Polyposis Patients
source: Cancer genomics & proteomics
authors: Fatima N, Chelius D, Luke B T, Yi M, Zhang T, Stauffer S, Stephens R, Lynch P, Miller K, Guszczynski T, Boring D, Greenwald P, Ali I Usummary/abstract:
Celecoxib, a selective inhibitor of cyclooxygenase-2 (Cox-2), was efficacious in clinical prevention trials of patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. To identify as yet poorly defined molecular determinants of celecoxib efficacy, a multidimensional serum fractionation approach was used coupled with nanospray tandem mass spectrometry to perform label-free global proteomic profiling of serum samples from the FAP/celecoxib prevention trial. Subsequently, the application of an algorithm for large-scale biomarker discovery on comparative serum proteomic profiles of pre- and post-celecoxib treatment samples identified 83 potentially celecoxib-responsive proteins from various cellular compartments, biological processes and molecular functions. Celecoxib modulation of some of these proteins was confirmed in serum samples of FAP patients and colorectal cancer cell lines by Western blotting. Thus, using a shotgun procedure to rapidly identify important celecoxib-modulated proteins, this pilot study has uncovered novel systemic changes some of which are highly relevant for carcinogenesis and vascular biology. Validation of selected markers, especially those involved in key signaling networks and those considered molecular indicators of cardiovascular pathology, in larger celecoxib clinical trials is expected to provide insights into the molecular mechanisms of celecoxib and the efficacy/toxicity issues related to its use as a chemopreventive agent.organization: University of Karachi
read more full text source
expertly curated content related to this topic
Hereditary Colorectal Cancerhttps://www.fapvoice.com/wp-content/uplo...
Macroscopic and Histologic Regression of Duodenal Polyposis with FOLFOX4 Chemotherapy for an Ileal Pouch Adenocarcin...Severe (stage IV) duodenal polyposis is ...
Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous PolyposisA Phase 2, randomized, double blind, pla...
Do NSAIDs Suppress Polyps in MUTYH-Associated Polyposis? A Case ReportPoster Presentation Background: MUTY...
Ileal Pouch Anal Anastomosis: Analysis of Outcome and Quality of Life in 3707 PatientsBACKGROUND : Ileal pouch anal anastomosi...
Different Surgical Strategies in the Treatment of Familial Adenomatous Polyposis: What’s the Role of the Ileal...BACKGROUND AND STUDY AIMS: Restorative ...
Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Survei...The primary objective of this chart revi...